Envista Holdings Corp
NYSE:NVSTMedical - Equipment & Services
+$0.76 today
- Market cap
- $3.81B
- Beta
- 0.89
- P/E (TTM)
- 62.0
- EPS (TTM)
- $0.41
Volume 1.92M
Average 2.94M
NVST Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Envista Holdings CorpNYSE: NVST
Revenue · Q3 FY2026 · quarter ended Oct 2026
Revenue grows, but more slowly than its trailing trend
Q3 FY2026 revenue of $691.5M rose 3.2% year over year, behind the +9.8% change in trailing-twelve-month revenue. Sequentially, it fell 5.3% from the prior quarter. Over 3 fiscal years it compounded at +1.9% a year.
Context
- Revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 11 analysts of $2.87B (+5.6%) for the fiscal year ending Dec 2026, a slowdown from the +8.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterOct 2026
- $691.5M-5.3% QoQ
- Last fiscal yearDec 2025
- $2.72B+8.3% YoY
- LTMOct 2026
- $2.88B+9.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.2% | +0.3% | -2.9 pp |
| 1 year | +8.3% | +5.6% | -2.7 pp |
| 3-year CAGR | +1.9% | +4.3% | +2.4 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 2.72B USD
- Year-over-year change
- +8.3%
- 4-year CAGR
- +2.0%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.72B | +8.3% |
| FY2024 | 2024-12-31 | 2.51B | -2.2% |
| FY2023 | 2023-12-31 | 2.57B | -0.1% |
| FY2022 | 2022-12-31 | 2.57B | +2.4% |
| FY2021 | 2021-12-31 | 2.51B | — |
Revenue vs competitors
How NVST compares with its peers on the latest reported figures
- NVST's LTM Oct 2026 revenue of $2.88B is the 3rd highest of the 11 companies compared; the peer median is $1.49B.
- Its year-over-year change of +9.8% is the 7th highest of 9, against a peer median of +18.2%.
- Over three fiscal years its annual growth of +1.9% compares with a peer median of +12.0%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $4.26B | +41.8% | +40.2% | |
| LTM Mar 2026 | $3.68B | -1.0% | -2.1% | |
| LTM Oct 2026 | $2.88B | +9.8% | +1.9% | |
| LTM Jun 2026 | $2.36B | +24.1% | +16.1% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $2.34B | +11.8% | +7.9% |
| LTM Jun 2026 | $2.16B | -9.0% | -0.7% | |
| LTM Jun 2026 | $830.44M | +24.9% | +2.5% | |
| LTM Mar 2026 | $669.43M | +13.3% | +22.8% | |
| LTM Jun 2026 | $165.26M | +23.1% | +38.4% | |
| LTM Jun 2026 | $0 | — | — | |
| LTM Jun 2026 | $0 | — | — | |
| Peer median (excluding NVST) | $1.49B | +18.2% | +12.0% | |
Competitors are the stored peer set for NVST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.51B | 2.57B | 2.57B | 2.51B | 2.72B |
| Cost of Revenue | 1.05B | 1.08B | 1.12B | 1.12B | 1.22B |
| Gross Profit | 1.46B | 1.49B | 1.45B | 1.39B | 1.5B |
| Gross Margin | 58.3% | 57.9% | 56.5% | 55.4% | 55.0% |
| Research & Development | 100.5M | 100.1M | 93.8M | 99.1M | 114M |
| Selling, General & Admin | 989.5M | 1.03B | 1.03B | 1.14B | 1.16B |
| Operating Expenses | 1.16B | 1.17B | 1.42B | 2.43B | 1.27B |
| Depreciation & Amortization | 151.9M | 162.1M | 162.6M | 123.1M | 116M |
| EBITDA | 524.3M | 522M | 490M | 279.5M | 329.8M |
| EBITDA Margin | 20.9% | 20.3% | 19.1% | 11.1% | 12.1% |
| Operating Income | 306.2M | 319.2M | 31.5M | (1.04B) | 225.7M |
| Operating Margin | 12.2% | 12.4% | 1.2% | -41.4% | 8.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 54.1M | 38.4M | 63.4M | 46.4M | 36.6M |
| Other Income / Expenses | (51.7M) | (35.3M) | (86.4M) | (46.5M) | (48.5M) |
| Income Before Tax | 254.5M | 283.9M | (54.9M) | (1.08B) | 177.2M |
| Pre-Tax Margin | 10.1% | 11.1% | -2.1% | -43.2% | 6.5% |
| Income Tax Expense | (9M) | 45.9M | 45.3M | 33.9M | 130.2M |
| Net Income | 340.5M | 243.1M | (100.2M) | (1.12B) | 47M |
| Net Margin | 13.6% | 9.5% | -3.9% | -44.6% | 1.7% |
| EPS (Basic) | 1.63 | 1.46 | (0.60) | (6.50) | 0.28 |
| EPS (Diluted) | 1.48 | 1.34 | (0.60) | (6.50) | 0.28 |
| Weighted Avg Shares | 161.2M | 162.9M | 166.9M | 172.2M | 168M |
| Weighted Avg Shares (Diluted) | 177.6M | 177.6M | 166.9M | 172.2M | 169.2M |
Envista Holdings Corp
NYSE:NVST
Intrinsic Alpha fair value
Locked
Current Price
$23.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.